Comorbidities Persist for the 90% of Patients With MASH and No Cirrhosis
MASH’s economic burden is substantial, particularly for patients with MASH and multiple comorbidities, even in the absence of cirrhosis.
Read MoreSep 30, 2024
MASH’s economic burden is substantial, particularly for patients with MASH and multiple comorbidities, even in the absence of cirrhosis.
Read MoreJul 30, 2024
As the earliest patients to be diagnosed with HIV age, early screening has become critical to address the impact of comorbidities in older patients with HIV.
Read More